PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073256 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Barbara Toffoli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Surgical and Health Sciences, University of Trieste, Cattinara Teaching Hospital Strada di Fiume, 34100 Trieste, Italy. Hauptthemen laut MEDLINE: Membrane Proteins, Lipase, Vascular Stiffness, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Trieste, Università degli Studi di Trieste—University of Trieste.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) corresponds to the condition of increased hepatic fat levels, which is the leading cause of hepatic failure and carcinoma. It is also an independent risk factor for cardiovascular disease (CVD) and mortality. MASLD can be due to obesity with insulin resistance and/or genetic predisposition, i.e., polymorphism in the patatin-like phospholipase domain-containing 3 (PNPLA3) gene. PNPLA3 polymorphism has been associated with increased hepatic fat levels, fibrosis, cirrhosis, and hepatocellular carcinoma, while its association with CVD remains to be fully understood. The aim of the current study was to examine whether the vascular phenotype of patients with MASLD differed between carriers and noncarriers of the PNPLA3 polymorphism. Adult patients with MASLD underwent clinical assessment, PNPLA3 genotyping, arterial tonometry for aortic stiffness measurement, and ultrasound examination of carotid arteries. In total, 117 patients with MASLD and no fibrosis (median hepatic stiffness was 4.71 kPa) were recruited. Carriers of the PNPLA3 polymorphism were younger and exhibited higher levels of ALT and APRI, as compared to wild-type subjects. On the other hand, carriers of the PNPLA3 polymorphism had not only a better metabolic profile (i.e., lower glucose and glycated hemoglobin) but also lower blood pressure, carotid intima-media thickness (IMT), and cardiovascular risk. In addition, PNPLA3 polymorphism was negatively correlated with aortic stiffness, which is a marker of arteriolosclerosis and vascular ageing. Our data are consistent with previous observations that in case of genetically-driven MASLD, there is an inverse association with common predictors of CVD. Our data support the view that the main contributors to CVD risk in patients with MASLD remain conventional cardiometabolic risk factors (i.e., age, glucose) that are more likely to be found in metabolic syndrome-related MASLD rather than genetically-driven MASLD, at least in the first stages of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Surgical and Health Sciences, University of Trieste, Cattinara Teaching Hospital Strada di Fiume, 34100 Trieste, Italy.
- UCO Medicina Clinica ASUGI, Cattinara Teaching Hospital, Strada di Fiume, 34100 Trieste, Italy.
- Centro Clinico Studi Fegato ASUGI, Maggiore Teaching Hospital, Piazza dell'Ospitale, 34100 Trieste, Italy.
- SSD Angiologia ASUGI, Cattinara Teaching Hospital, Strada di Fiume, 34100 Trieste, Italy.
- SS Endocrinologia ASUGI, Cattinara Teaching Hospital, Strada di Fiume, 34100 Trieste, Italy.
ORCID-Profile: Barbara Toffoli, Andrea Grillo, Saveria Lory Crocè, Stella Bernardi
Förderung
- University of Trieste
- Università degli Studi di Trieste—University of Trieste
Zitieren
APA
Toffoli, B., Comar, C., Grillo, A., Barbato, V., Vincis, E., Baldi, V., Berti, S., Volpato, T., Zorat, F., Crocè, S. L., Emmi, G., Fabris, B., Puato, M., & Bernardi, S. (2025). PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073256
Vancouver
Toffoli B, Comar C, Grillo A, Barbato V, Vincis E, Baldi V, et al. PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073256
BibTeX
@article{Toffoli2025,
author = {Toffoli, Barbara and Comar, Consuelo and Grillo, Andrea and Barbato, Vincenzo and Vincis, Emanuele and Baldi, Veronica and Berti, Silvia and Volpato, Teresa and Zorat, Francesca and Crocè, Saveria Lory and Emmi, Giacomo and Fabris, Bruno and Puato, Massimo and Bernardi, Stella},
title = {PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073256}
}
EUVIMED